Our platform introduces a new class of mechanism-based therapies built around a metabolic switch, with potential to address diverse fields including oncology, neuroscience, immunology, infectious diseases, gene and cell therapy, regenerative medicine, metabolic and mitochondrial health, organ resilience, healthy aging, evidence-based nutraceuticals, and cellular beauty.
We invite qualified collaborators to explore technology-transfer partnerships and develop tailored applications aligned with their specific fields of interest. Investors, government agencies, and industry partners are invited to sign an NDA and review the supporting validated data, intellectual-property position, and collaboration opportunities underlying this emerging platform.